v3.26.1
Equity-Accounted Investees and Joint Business - Movement in the investments in equity-accounted investees (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Movement in the investments in equity-accounted investees      
Balance at 1 January € 69 € 421 € 1,498
Acquisitions 39 41 20
Share of profit / (losses) (4) 9 63
Share of other comprehensive income / translation differences (3) (19) (62)
Collected dividends   (7) (7)
Impairment losses (4)    
Uncollected dividends   (6) (1)
Transfers   (370) (1,090)
Balance at 31 December 97 69 421
Profit of equity accounted investees with similar activity to that of the Group (8) 37 64 [1]
Total equity accounted investees with similar activity to that of the Group      
Movement in the investments in equity-accounted investees      
Balance at 1 January 69 418 1,494
Acquisitions   41 20
Share of profit / (losses)   9 64
Share of other comprehensive income / translation differences   (19) (62)
Collected dividends   (7) (7)
Uncollected dividends   (6) (1)
Transfers   (367) (1,090)
Balance at 31 December   69 418
Shanghai RAAS Blood Products Co., Ltd.      
Movement in the investments in equity-accounted investees      
Balance at 1 January   361 1,453
Share of profit / (losses)   13 62
Share of other comprehensive income / translation differences     (57)
Collected dividends   (7) (7)
Transfers   (367) (1,090)
Balance at 31 December     361
Gains (losses) on sales of investments accounted for using equity method   34  
Grifols Egypt Plasma Derivatives S.A.E.      
Movement in the investments in equity-accounted investees      
Balance at 1 January 63 46 36
Acquisitions 20 41 20
Share of profit / (losses) (4)   (1)
Share of other comprehensive income / translation differences (3) (24) (9)
Balance at 31 December 76 63 46
BioDarour P.J.S. Co.      
Movement in the investments in equity-accounted investees      
Balance at 1 January 6 11 5
Share of profit / (losses)   (4) 3
Share of other comprehensive income / translation differences   5 4
Impairment losses (4)    
Uncollected dividends   (6) (1)
Balance at 31 December 2 6 11
Grifols Canada Plasma, Inc.      
Movement in the investments in equity-accounted investees      
Acquisitions 19    
Balance at 31 December € 19    
Total of the rest of equity accounted investees      
Movement in the investments in equity-accounted investees      
Balance at 1 January   3 4
Share of profit / (losses)     (1)
Transfers   (3)  
Balance at 31 December     3
Albajuna Therapeutics, S.L      
Movement in the investments in equity-accounted investees      
Balance at 1 January     1
Share of profit / (losses)     (1)
Mecwins, S.A      
Movement in the investments in equity-accounted investees      
Balance at 1 January   3 3
Transfers   € (3)  
Balance at 31 December     € 3
[1] (See Note 2.d)